Re: Health Data RDA – Visualisation
-
Discussion
-
Greetings,
I am looking forward to our follow-up meeting (in 30 minutes for the first meeting). Please note that Doodle has the time correct and is corrected below.
The agenda includes:
* An overview of the work to date
* Adding individuals who would like to contribute to the map
* Reviewing the categories and contents
If you would like to look at the current state of the simplified visualization, please see: https://www.mindmeister.com/873929998?t=1x86Y9RMa5
Cheers,
Leslie
The follow-up meeting for “Health Data RDA – Visualisation”will be:
Thursday, March 30, 2017 9:00 (CDT-US) / 16:00 (CET-Europe)
and
Thursday, March 30, 2017 17:00 (CDT-US) / Friday, March 31, 2017 9:00 (AEDT – Australia)
This link should work for both meetings:
https://global.gotomeeting.com/join/765004669
Dial-in phone numbers:
Access Code: 765-004-669
United States: +1 (646) 749-3117
Australia: +61 2 8355 1038
Austria: +43 1 2530 22500
Belgium: +32 27 00 6375
Canada: +1 (647) 497-9373
Denmark: +45 32 72 03 69
Finland: +358 972 52 2971
France: +33 170 950 590
Germany: +49 69 5880 7802 72
Ireland: +353 15 621 583
Italy: +39 0 230 57 81 80
Netherlands: +31 707 709 520
New Zealand: +64 9 282 9510
Norway: +47 21 93 37 37
Spain: +34 932 75 1230
Sweden: +46 775 757 471
Switzerland: +41 445 1124 85
United Kingdom: +44 20 3713 5011
I look forward to the discussion.
Cheers,
Leslie
Leslie D. McIntosh, PhD, MPH
Assistant Professor
Washington University in St. Louis
660 S. Euclid Box 8118
St. Louis, MO 63110
314.747.7959 (O) or 314.200.5838 (C)
________________________________
The materials in this message are private and may contain Protected Healthcare Information or other information of a sensitive nature. If you are not the intended recipient, be advised that any unauthorized use, disclosure, copying or the taking of any action in reliance on the contents of this information is strictly prohibited. If you have received this email in error, please immediately notify the sender via telephone or return mail.
Log in to reply.